OH HB588 | 2023-2024 | 135th General Assembly
Status
Spectrum: Partisan Bill (Republican 2-0)
Status: Introduced on May 15 2024 - 25% progression
Action: 2024-05-21 - Referred to committee: Public Health Policy
Pending: House Public Health Policy Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on May 15 2024 - 25% progression
Action: 2024-05-21 - Referred to committee: Public Health Policy
Pending: House Public Health Policy Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To enact section 4729.521 of the Revised Code to prohibit drug manufacturers and wholesalers from taking certain actions regarding reimbursements made to 340B covered entities.
Title
Regards drug reimbursements made to 340B covered entities
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2024-05-21 | House | Referred to committee: Public Health Policy |
| 2024-05-15 | House | Introduced |
Subjects
Commerce : Insurance
Health and Human Services : Health Care
Health and Human Services : Medicaid
House Public Health Policy Committee
Health and Human Services : Health Care
Health and Human Services : Medicaid
House Public Health Policy Committee
Code Citations
Ohio State Sources
| Type | Source |
|---|---|
| Summary | https://www.legislature.ohio.gov/legislation/135/hb588 |
| Text | https://search-prod.lis.state.oh.us/solarapi/v1/general_assembly_135/bills/hb588/IN/00/hb588_00_IN?format=pdf |
